Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Athenex, Inc. (ATNX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 91,730,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for cancer treatment. Co.'s platforms are: Oncology Innovation Platform, which is focused on the research and development of its proprietary drugs; Commercial Platform, which is focused on the sales and marketing of its drugs and the market development of its proprietary drugs; and Global Supply Chain Platform, which provides supply of active pharmaceutical ingredients for its clinical and commercial efforts. Co.'s clinical pipeline in the Oncology Innovation Platform is derived from Cell Therapy, Orascovery, based on a P-glycoprotein pump inhibitor, and Src Kinase inhibition.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 30,000
Total Buy Value $0 $0 $0 $13,319
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 371
  Page 3 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cook Timothy Devere See Remarks   •       –      –    2022-11-18 4 A $0.19 $500 D/D 2,578 25,954     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2022-11-18 4 A $0.19 $11,400 D/D 58,762 3,876,266     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2022-11-18 4 A $0.19 $4,900 D/D 25,257 439,347     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2022-11-04 4 A $0.20 $4,900 D/D 25,103 414,090     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2022-11-04 4 A $0.20 $11,400 D/D 58,402 3,817,504     -
   Cook Timothy Devere See Remarks   •       –      –    2022-11-04 4 A $0.20 $500 D/D 2,561 23,376     -
   Cook Timothy Devere See Remarks   •       –      –    2022-10-21 4 A $0.18 $500 D/D 2,747 20,815     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2022-10-21 4 A $0.18 $4,900 D/D 26,923 388,987     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2022-10-21 4 A $0.18 $11,400 D/D 62,637 3,759,102     -
   Fok Manson Director   –       •      –    2022-10-07 4 A $0.24 $7,500 D/D 31,133 2,058,235     -
   Davis Stephanie A Director   –       •      –    2022-10-07 4 A $0.24 $4,750 D/D 19,717 61,921     -
   Cook Timothy Devere See Remarks   •       –      –    2022-10-07 4 A $0.24 $500 D/D 2,076 18,068     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2022-10-07 4 A $0.24 $11,400 D/D 47,323 3,696,465     -
   Wu Jinn Director   –       •      –    2022-10-07 4 A $0.24 $8,500 D/D 35,284 520,067     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2022-10-07 4 A $0.24 $4,900 D/D 20,340 362,064     -
   Tsang Benson Kwan Hung Director   –       •      –    2022-10-07 4 A $0.24 $11,500 D/D 47,737 100,309     -
   Spiegel Robert J. Director   –       •      –    2022-10-07 4 A $0.24 $3,000 D/D 12,453 29,700     -
   Vierling John Director   –       •      –    2022-10-07 4 A $0.24 $8,500 D/D 35,284 70,609     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2022-09-23 4 A $0.24 $11,400 D/D 47,303 3,649,142     -
   Cook Timothy Devere See Remarks   •       –      –    2022-09-23 4 A $0.24 $500 D/D 2,075 15,992     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2022-09-23 4 A $0.24 $4,900 D/D 20,333 341,724     -
   Cook Timothy Devere See Remarks   •       –      –    2022-09-16 4 D $0.41 $224 D/D (548) 13,917     -
   Cook Timothy Devere See Remarks   •       –      –    2022-09-16 4 OE $0.00 $0 D/D 2,250 14,465     -
   Lang Daniel Pres Cell Therapy, VP Corp Dev   •       –      –    2022-09-16 4 D $0.41 $1,766 D/D (4,323) 81,590     -
   Lang Daniel Pres Cell Therapy, VP Corp Dev   •       –      –    2022-09-16 4 OE $0.00 $0 D/D 12,500 85,913     -
  371 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us